MIAMI, April 03, 2018 -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced that is has released its investor presentation for public view.
The Company has uploaded its investor presentation and accompanying video on its website at:
https://progressivecareus.com/investor-presentation-march-2018/
The presentation contains a brief overview of the company, its operations, 2017 results, and agenda for the coming year.
“We feel it is important to our shareholders and the investing public to see me deliver our Company’s story,” stated S. Parikh Mars, CEO. “We hope to build upon this opportunity by developing a forum for more direct access to the Company and more content curated and produced by me personally. We think this level of transparency will build confidence in the market and provide an outlet for us to begin leading the conversation on a variety of topics in business and healthcare.”
Get connected and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care
Progressive Care Inc. (OTCQB:RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Contact Armen Karapetyan Senior Advisor Business Development [email protected] www.progressivecareus.com www.pharmcopharmacy.com


Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review 



